Filing Details

Accession Number:
0000711377-19-000032
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-08-07 11:01:28
Reporting Period:
2019-08-05
Accepted Time:
2019-08-07 11:01:28
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
711377 Neogen Corp NEOG In Vitro & In Vivo Diagnostic Substances (2835) 382367843
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1651434 Edward John Adent 822 7Th Street, Suite 740
Greeley CO 80631
President & Ceo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-08-05 40,002 $51.29 44,302 No 4 M Direct
Common Stock Disposition 2019-08-05 31,489 $69.03 12,813 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Common Stock (Right to Buy) Disposition 2019-08-05 40,002 $0.00 40,002 $51.29
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
149,999 2022-08-17 No 4 M Direct
Footnotes
  1. Options were granted on 7/17/2017, have five year lives and vest in equal 20% annual installments on each of the first five anniversary dates of the grant
  2. Mr. Adent sold these shares to cover the cost of the exercise